Shares of The Procter & Gamble Company (NYSE:PG - Get Free Report) were down 1% on Monday . The company traded as low as $170.43 and last traded at $172.12. Approximately 1,599,552 shares changed hands during trading, a decline of 76% from the average daily volume of 6,692,492 shares. The stock had previously closed at $173.82.
Analyst Upgrades and Downgrades
PG has been the subject of several research reports. DA Davidson upgraded Procter & Gamble from a "neutral" rating to a "buy" rating and lifted their price target for the company from $160.00 to $209.00 in a report on Monday, November 25th. JPMorgan Chase & Co. upped their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a report on Thursday, September 19th. Wolfe Research upgraded Procter & Gamble to a "strong-buy" rating in a research note on Friday, August 23rd. Hsbc Global Res raised Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Finally, Royal Bank of Canada restated a "sector perform" rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $180.45.
Read Our Latest Report on PG
Procter & Gamble Trading Down 1.6 %
The stock has a market capitalization of $402.90 billion, a PE ratio of 29.68, a P/E/G ratio of 3.75 and a beta of 0.44. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average price of $170.76 and a 200 day moving average price of $169.40.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company's quarterly revenue was down .6% on a year-over-year basis. During the same period in the previous year, the company earned $1.83 earnings per share. Equities analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's payout ratio is currently 69.48%.
Insider Buying and Selling
In other news, insider Susan Street Whaley sold 634 shares of the stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This represents a 3.17 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business's stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company's stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 83,080 shares of company stock valued at $14,629,038. Corporate insiders own 0.18% of the company's stock.
Institutional Investors Weigh In On Procter & Gamble
A number of large investors have recently added to or reduced their stakes in PG. Concurrent Investment Advisors LLC raised its stake in Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company's stock valued at $16,300,000 after purchasing an additional 4,035 shares in the last quarter. Radnor Capital Management LLC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at about $5,705,000. Welch Group LLC lifted its holdings in shares of Procter & Gamble by 0.9% in the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company's stock valued at $56,094,000 after acquiring an additional 2,990 shares during the last quarter. Swiss National Bank increased its stake in Procter & Gamble by 0.6% during the third quarter. Swiss National Bank now owns 7,005,790 shares of the company's stock worth $1,213,403,000 after acquiring an additional 39,000 shares during the last quarter. Finally, Curi RMB Capital LLC raised its position in Procter & Gamble by 20.3% during the third quarter. Curi RMB Capital LLC now owns 21,655 shares of the company's stock valued at $3,751,000 after purchasing an additional 3,652 shares during the period. Institutional investors own 65.77% of the company's stock.
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
